Mobile multidisciplinary pain management program for children and young adults with intellectual disability, autism, or multiple disabilities
Official title: Impact and Determinants of Success of a Mobile Multidisciplinary Intervention System Specialized in Pain Management for Patients With Moderate to Severe Intellectual Development Disorder, Isolated or Associated With an ASD or Multiple Disability - MoDIDol
Run by University Hospital, Brest · NCT07302048 · Data updated 2026-11-12
This project will try a mobile multidisciplinary team approach to improve how pain is identified and treated for children and young adults (0–24) with intellectual disability, autism, or multiple disabilities.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | Any age to 24 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 1 site (Brest) |
| Status | Recruiting |
| Started | October 14, 2025 |
| Main results expected | April 20, 2028 |
| Study ends | April 20, 2028 |
| Registry record updated | December 24, 2025 |
| Trial ID | NCT07302048 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people under 25 with a medical diagnosis of intellectual disability (with or without ASD or multiple disabilities), a probable or definite pain diagnosis confirmed by the MoDIDol team, a PGIC score ≥ 3, and who live in or receive care in the designated Brittany departments with French health insurance.
✕Probably not a fit
Patients are unlikely to benefit if they live or receive care outside the specified departments, have more than three residences/care settings, or whose parents/guardians cannot provide informed consent or complete study questionnaires due to language or comprehension limits.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
A mobile multidisciplinary team (MoDIDol) based at Brest University Hospital provides tailored pain assessment and management for patients aged 0–24 with intellectual developmental disorder, ASD, or multiple disabilities. Care is delivered on request from families or professionals and includes multidisciplinary follow-up consultations approximately every six weeks. Study data are collected through three questionnaire sessions spaced three months apart and qualitative interviews with a sample of parents and professionals at six-month intervals. The program emphasizes the patient's social and family environment, living context, and clinical characteristics to guide individualized care plans.
Why it matters
Potential benefit: If successful, this approach could lead to better recognition and control of pain, fewer pain-related behavioral problems, and improved support for families and caregivers.
How similar studies have gone: Mobile multidisciplinary pain programs for this specific population are uncommon and not yet validated, so this approach is relatively novel though multidisciplinary pain care has shown benefits in other clinical groups.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged from birth up to 24 years inclusive (i.e., under 25 years old) * Medical diagnosis of intellectual disability (ID), isolated or associated with autism spectrum disorder (ASD), developmental disorder (DD), or profound multiple disabilities, based on international classification systems (ICD-11 or DSM-5) * Confirmed probable or definite pain diagnosis, as validated by the MoDIDol team * PGIC score ≥ 3 * Living in or receiving care in the departments of Finistère, Côtes-d'Armor, or Morbihan * Written informed consent provided by parents, legal guardians, or holders of parental authority, authorizing data collection for research and publication purposes * Affiliated with or benefiting from a French national health insurance scheme Exclusion Criteria: * More than three places of residence and/or care settings * Parents or legal guardians who do not have sufficient language or comprehension skills to provide informed consent or complete study questionnaires
Where it's running
-
CHU de Brest - Hôpital Morvan
Brest, France Recruiting
Study contacts
- Principal investigator: Philippe J LE MOINE, MD — CHU de Brest
- Study coordinator: Philippe LE MOINE, MD
- Email: philippe.lemoine@chu-brest.fr
- Phone: +332 98 22 39 56
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PPF3 vs placebo in children and teens with autism
This trial tests whether PPF3 helps improve symptoms in children and adolescents with autism compared to placebo.
-
Gut barrier and gut microbes in children with autism
This trial will test whether a one-month course of postbiotic supplements can improve gut symptoms and behavior in children with autism aged 3–8.
-
Follow-up of adolescents with autism and psychotic symptoms in Sweden
We are seeing if teens with autism who report psychotic symptoms still show functional impairments and psychiatric symptoms years later.
-
CRUSH curriculum for romance and sexual health for autistic young adults
This project will try the CRUSH program—a group course plus one-to-one coaching—to teach sexual health and dating skills to autistic adults ages 18 to 30.
-
Virtual reality to improve emotion understanding in children with autism
This project will test whether an Oculus virtual-reality program helps children with autism better recognize and understand emotions compared with a traditional intervention.
-
Emotional processing in adults with intellectual developmental disorder
This project will test whether adults with intellectual developmental disorder have trouble recognizing emotions and whether those difficulties are linked to attention and eye-movement processes compared with adults without IDD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.